MedPath

Does Altering Magill Forceps Affect Nasal Intubation Time

Not Applicable
Completed
Conditions
Dental Surgery
Nasal Intubation
Pediatrics
Interventions
Device: Intubation with Magill forceps
Device: Intubation with altered Magill forceps
Registration Number
NCT02109211
Lead Sponsor
University of Saskatchewan
Brief Summary

The purpose of this study is to see whether altering the angle of the Magill forceps by 45 degrees will affect nasal intubation time in pediatric dental surgery patients.

The null hypothesis is that their will be no difference between the nasal intubation times of those patients intubated with the conventional Magill forceps and those intubated with the altered Magill forceps.

Detailed Description

The Magill forceps (MF) is the instrument of choice for nasal tracheal intubation (NTI). It serves as an aid for inserting the endotracheal tube tip past the vocal cords during NTI. NTI is preferred over oral tracheal intubation (ETT) in certain instances such as pediatric dental surgery. This is because NTI permits excellent access to all intraoral structures while reducing risk of inadvertent displacement of an orotracheal tube. Although there is literature looking at MF design alterations to reduce complications and improve its other uses, there is no literature examining the effect of design alterations on time to successful intubate (TTI). Our study premise is based on the concept that a MF is not ideally structured for the pediatric airway anatomy. Knowing that the larynx is considerably anterior in the pediatric airway, we hypothesized that a + 45° angle change 2cm from the tip of the MF will help align the direction the instrument carrying the endotracheal tube with the anatomic direction of the airway and thus help reduce the TTI.. If a reduction in TTI can be shown it would be of significant benefit and could add another tool for NTI. Even though, the current MF has been satisfactory in its use, this should not deter us from looking for opportunities to improve on the current standard. To test this hypothesis, we will include a hundred participants as part of an open label, controlled, single center, and randomized study in which 50 patients will be intubated with the conventional MF and 50 patients will be intubated with the altered MF. We expect the results to show at least a 5 second reduction in TTI and thus be statistically significant with a p value less than 0.05 for our sample size. Our expected conclusion is that a reduced TTI is clinically beneficially as it will reduce apnea time in the pediatric patients, a population with known physiological limitations in respiratory reserve. This, in turn, could point to a reduction in intra-operative and post-operative respiratory complications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
133
Inclusion Criteria
  • age 0-15yrs, ASA < or = 2, Mallampati < or = 3, presenting of dental surgery
Exclusion Criteria
  • patients at risk for aspiration, upper airway abnormalities, known difficult airway

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard care - Magill forcepsIntubation with Magill forcepsPatients will be intubated, as per standard care, with Magill forceps.
Altered Magill forcepsIntubation with altered Magill forcepsPatients will be intubated with modified Magill forceps.
Primary Outcome Measures
NameTimeMethod
Time to intubateRight after measurement

Having a stopwatch to time how long it takes for the intubator to place initiate direct laryngoscopy until the time of detection of end tidal carbon dioxide on the monitor

Secondary Outcome Measures
NameTimeMethod
Cormack-Lehane glottis viewimmediately

what view is attained through laryngoscopy

Number of attempts to nasal tracheal intubationonce intubation completed
Number of technique failuresonce intubation is complete

To see which other methods of intubation, if any, were needed/used to successfully intubate patient

Trial Locations

Locations (1)

Prairieview Surgical Center

🇨🇦

Saskatoon, Saskatchewan, Canada

© Copyright 2025. All Rights Reserved by MedPath